These results reveal that bone marrow cell-derived MYDGF was both sufficient and necessary to regulate hepatic inflammation, lipogenesis, hepatic steatosis, and metabolic disorders in NAFLD mice. The gene discussed is MYDGF; the disease is metabolic dysfunction-associated steatotic liver disease.